Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000009265
JPRN-UMIN000009265CompletedPhase 3

The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial - The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial

Hiroshima University Hospital0 sites44 target enrollmentStarted: November 10, 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
44
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1, Patients with alcoholic liver diseases. 2,Patients with viral liver diseases, autoimmune hepatitis, and primary biliary cirrhosis. 3, Paitents with pregnancy. 4, Patients who have allergy against ingredients of azithromicin. 5, Patients who have allergy against other macrolides and ketolides. 6, Patients with liver cirrhosis,liver failure including severe liver function test, hepatocellular carcinoma in the liver and other organs. 7, Patients with severe heart diseases. 8, Patients with hereditary fructose intolerance, glucose-galactose malabsorption, and sucrase-isomaltase deficiency. 9, Medical doctors decided the patients inappropriate.

Investigators

Similar Trials

Not yet recruiting
Phase 3
Benefits of systemically administered adjunctive azithromycin in periodontitis patients non-responsive to initial non-surgical periodontal therapy.Periodontitis patients' non-responsive to initial periodontal therapyOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12619000597190The University of Queensland40
Active, not recruiting
Phase 4
A clinical trial to study the effect of Azithromycin on Chronic Periodontitis patients
CTRI/2017/12/011015Dr Divija Pelapudi
Not yet recruiting
Phase 2
The effect of azythromycin in the control of refractory asthma patientsSevere persistent asthma.Severe persistent asthmaJ45.5
IRCT20100102002954N21Shahroud University of Medical Sciences112
Completed
Phase 3
The effect of azithromycin in treatment of COVID19
IRCT20200415047092N1Tehran University of Medical Sciences110
Completed
Not Applicable
Comparison effect of Azithromycin and Amoxiclave in treatment of acute sinusitis.Sinusitis.Diseases of respiratory system
IRCT201401046252N5Shahrekord University of Medical Sciences78